Health and Science / Pharmaceuticals
Pfizer Beats Q4 2026 Earnings Estimates Despite Covid Product Decline
Pfizer (PFE) has released its Q4 2026 earnings, surpassing expectations despite a decrease in demand for its COVID-19 products. The company reaffirmed its financial outlook for 2026, emphasizing its long-term investments and cost-saving ini...